Vertex Pharmaceuticals(VRTX)
$515.02-5.64 (-1.08%)
VRTX
Vertex Pharmaceuticals ownership
$515.02
At close:-5.64 (-1.08%)
Want to see VRTX full AI Analyst Report?
Vertex Pharmaceuticals (VRTX) Ownership - Who Owns Vertex Pharmaceuticals?
6,861 Followers
Vertex Pharmaceuticals (VRTX) Ownership Overview
- 0.20% Insiders
- 35.43% Mutual Funds
- 27.93% Other Institutional Investors
- 30.94% ETFs
- 5.50% Public Companies and Individual Investors
The ownership structure of Vertex Pharmaceuticals (VRTX) stock is a mix of institutional, retail, and individual investors. Approximately 94.30% of the company’s stock is owned by Institutional Investors, 0.20% is owned by Insiders, and 5.50% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Vertex Pharmaceuticals (VRTX) stock is a mix of institutional, retail, and individual investors. Approximately 94.30% of the company’s stock is owned by Institutional Investors, 0.20% is owned by Insiders, and 5.50% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | Tweedy Browne Co Llc | $13,599,857 | |
| Sep 30, 2026 | Bridgewater Associates, Lp | $18,253,911 | |
| Sep 30, 2026 | Manning & Napier Advisors Llc | $261,405 | |
| Sep 30, 2026 | Gamco Investors, Inc. Et Al | $209,124 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 23,803,111 | Institution | 9.39% | 12,259,078,227 |
| Vanguard | 19,245,666 | Institution | 7.59% | 9,911,902,903 |
| Vanguard Index Funds | 17,715,576 | Institution | 6.99% | 9,123,875,952 |
| Ishares | 17,529,695 | Institution | 6.91% | 9,028,143,519 |
| Growth Fund Of America | 12,908,237 | Institution | 5.09% | 6,648,000,220 |
| Spdr | 10,561,766 | Institution | 4.17% | 5,439,520,725 |
| Invesco | 9,969,645 | Institution | 3.93% | 5,134,566,568 |
| Investment Co Of America | 6,269,142 | Institution | 2.47% | 3,228,733,513 |
| American Balanced Fund | 5,558,357 | Institution | 2.19% | 2,862,665,022 |
| Amcap Fund | 4,734,921 | Institution | 1.87% | 2,438,579,013 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 17,715,576 | Institution | 6.99% | 9,123,875,952 |
| Growth Fund Of America | 12,908,237 | Institution | 5.09% | 6,648,000,220 |
| Investment Co Of America | 6,269,142 | Institution | 2.47% | 3,228,733,513 |
| American Balanced Fund | 5,558,357 | Institution | 2.19% | 2,862,665,022 |
| Amcap Fund | 4,734,921 | Institution | 1.87% | 2,438,579,013 |
| Fidelity Concord Street Trust | 4,575,593 | Institution | 1.80% | 2,356,521,907 |
| New Perspective Fund | 3,366,011 | Institution | 1.33% | 1,733,562,985 |
| Capital World Growth & Income Fund | 2,377,362 | Institution | 0.94% | 1,224,388,977 |
| Washington Mutual Investors Fund | 1,975,814 | Institution | 0.78% | 1,017,583,726 |
| Vanguard Specialized Funds | 1,890,142 | Institution | 0.75% | 973,460,933 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard S&P 500 ETF, VOO ETF | 6,734,951 | Institution | 2.66% | 3,764,029,415 |
| Vanguard Total Stock Market ETF, VTI ETF | 6,353,420 | Institution | 2.51% | 3,550,799,370 |
| Invesco QQQ Trust, QQQ ETF | 5,442,652 | Institution | 2.15% | 2,833,771,190 |
| iShares Core S&P 500 ETF, IVV ETF | 3,411,226 | Institution | 1.35% | 1,776,088,929 |
| State Street SPDR S&P 500 ETF Trust, SPY ETF | 3,141,716 | Institution | 1.24% | 1,685,373,548 |
| SPDR S&P 500 ETF Trust CDI, AU:SPY ETF | 3,040,750 | Institution | 1.20% | 1,446,423,960 |
| Vanguard Growth ETF, VUG ETF | 2,800,547 | Institution | 1.10% | 1,565,169,707 |
| Health Care Select Sector SPDR Fund, XLV ETF | 1,861,686 | Institution | 0.73% | 998,701,455 |
| iShares Biotechnology ETF, IBB ETF | 1,623,113 | Institution | 0.64% | 845,090,015 |
| Invesco NASDAQ 100 ETF, QQQM ETF | 1,251,423 | Institution | 0.49% | 651,565,899 |
FAQ
Who Owns Vertex Pharmaceuticals (VRTX)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 94.30% of the company's stock is held by institutional investors, 0.20% is held by insiders, and 5.50% is held by public companies and individual investors.
What percentage of Vertex Pharmaceuticals (VRTX) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 94.30% of Vertex Pharmaceuticals (VRTX) stock is held by institutional investors: 35.43% by mutual funds, 30.94% by ETFs and 27.93% by other institutional investors.
What percentage of Vertex Pharmaceuticals (VRTX) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 5.50% of Vertex Pharmaceuticals (VRTX) stock is held by public companies and individual investors.
Who owns the most shares of Vertex Pharmaceuticals (VRTX)?
BlackRock, Inc. owns the most shares of Vertex Pharmaceuticals (VRTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

